BIA
ROIV icon

Bell Investment Advisors’s Roivant Sciences ROIV Stock Holding History

Bell Investment Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.2K Sell
1,446
-25
-2% -$739 0.01% 271
2026
Q1 		$40.7K Buy
1,471
+25
+2% +$642 0.01% 286
2025
Q4 		$31.4K Buy
1,446
+375
+35% +$7.4K 0.01% 329
2025
Q3 		$16.2K Sell
1,071
-148
-12% -$1.83K ﹤0.01% 477
2025
Q2 		$13.7K Buy
1,219
+406
+50% +$4.4K ﹤0.01% 554
2025
Q1 		$8.2K Sell
813
-99
-11% -$1.07K ﹤0.01% 683
2024
Q4 		$10.8K Buy
912
+165
+22% +$1.95K ﹤0.01% 573
2024
Q3 		$8.62K Buy
747
+151
+25% +$1.72K ﹤0.01% 677
2024
Q2 		$6.3K Hold
596
– – ﹤0.01% 815
2024
Q1 		$6.28K Hold
596
– – ﹤0.01% 804
2023
Q4 		$6.69K Buy
596
+317
+114% +$3.09K ﹤0.01% 726
2023
Q3 		$3.26K Sell
279
-114
-29% -$1.29K ﹤0.01% 1035
2023
Q2 		$3.96K Hold
393
– – ﹤0.01% 940
2023
Q1 		$2.9K Hold
393
– – ﹤0.01% 1060
2022
Q4 		$3.14K Buy
+393
New +$2.19K ﹤0.01% 1046
2021
Q4 		$0 Buy
+48
New +$399 ﹤0.01% 1920

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Bell Investment Advisors's ROIV Position: Q2 2026 in Review

Bell Investment Advisors reduced its Roivant Sciences (ROIV) stake by 1.7% in Q2 2026, selling an estimated $739 and leaving 1,446 shares worth $51.2K. The position accounts for 0.01% of the portfolio, ranked #271.

Bell Investment Advisors first reported a position in ROIV in Q4 2021 and has held it in 16 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Bell Investment Advisors held 1,446 shares of Roivant Sciences worth $51.2K as of Q2 2026.
  • Bell Investment Advisors sold 25 Roivant Sciences shares in Q2 2026, an estimated $739.
  • Roivant Sciences made up 0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #271 holding.
  • Bell Investment Advisors first reported a position in Roivant Sciences in Q4 2021 and has held it in 16 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.